Management of non-epithelial ovarian tumours

Oncology

Volumn 57, Issue 2, 1999, Pages 89-98

  Bridgewater, John A ^a   Rustin, Gordon J S ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

Germ cell; Granulosa cell; Malignancy, ovarian; Mixed mullerian tumour; Stromal tumour; Tumour markers

Indexed keywords

ANTIESTROGEN; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; VINBLASTINE; VINCRISTINE;

ADIPOCYTE; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANDROBLASTOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; GERM CELL TUMOR; GRANULOSA CELL; HISTOLOGY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; META ANALYSIS; MIXED TUMOR; OVARY METASTASIS; OVARY TUMOR; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME; THECOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; GERMINOMA; GRANULOSA CELL TUMOR; HUMANS; MIXED TUMOR, MULLERIAN; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; POPULATION SURVEILLANCE; RADIOTHERAPY, ADJUVANT; THECOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 0032841581     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012014     Document Type: Review

References (131)

1. Fox H, Agrawal K, Langley FA: A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis. Cancer 1975;35:231-241.
2. Malmstrom H, Hogberg T, Risberg B, Simonsen E: Granulosa cell tumors of the ovary: Prognostic factors and outcome. Gynecol Oncol 1994;52/1:50-55.
3. Schwartz PE, Smith JP: Treatment of ovarian stromal tumors. Am J Obstet Gynecol 1976; 125:402-411.
4. Bjorkholm E, Silfversward C: Prognostic factors in granulosa-cell tumors. Gynecol Oncol 1981;11/3:261-274.
5. Miller B, Barron B, Wan J, Delmore J, Silva E, Gershenson D: Prognostic factors in adult granulosa cell tumor of the ovary. Cancer 1997;79:1951-1955.
6. Ohel G, Kaneti H, Schenker JG: Granulosa cell tumors in Israel: A study of 172 cases. Gynecol Oncol 1983;15/2:278-286.
7. Antolic ZN, Kovacic J, Rainer S: Theca and granulosa cell tumors and endometrial adenocarcinoma. Gynecol Oncol 1980;10:273-278.
8. Goldston W, Johnston W, Fetter B, Parker R, Wilbanks G: Clinicopathologic studies in feminizing tumors of the ovary. I. Some aspects of the pathology and therapy of granulosa cell tumors. Am J Obstet Gyncol 1972;112:422-429.
9. Nakashima N, Young RH, Scully RE: Androgenic granulosa cell tumors of the ovary. A clinicopathologic analysis of 17 cases and review of the literature. Arch Pathol Lab Med 1984;108: 786-791.
10. Gurusinghe C, Healy D, Jobling T, Mamers P, Burger H: Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue. Gynecol Oncol 1995;57/1:27-32.
11. Jobling T, Mamers P, Healy D, MacLachlan V, Burger H, Quinn M, Rome R, Day A: A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol 1994;55/2: 285-289.
12. Boggess JF, Soules MR, Goff BA, Greer BE, Cain JM, Tamimi HK: Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecol Oncol 1997;64:64-69.
13. Rodgers KE, Marks JF, Ellefson DD, Yanagihara DL, Tonetta SA, Vasilev SA, Morrow CP, Montz FJ, diZerega GS: Follicle regulatory protein: A novel marker for granulosa cell cancer patients. Gynecol Oncol 1990;37:381-387.
14. Gustafson ML, Lee MM, Scully RE, Moncure AC, Hirakawa T, Goodman A, Muntz HG, Donahoe PK, MacLaughlin DT, Fuller AF Jr: Mullerian inhibiting substance as a marker for ovarian sex-cord tumor. N Engl J Med 1992; 326:466-471.
15. Rey RA, Lhomme C, Marcillac I, Lahlou N, Duvillard P, Josso N, Bidart JM: Antimullerian hormone as a serum marker of granulosa cell tumors of the ovary: Comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol 1996;174:958-965.
16. Biscotti CV, Hart WR: Juvenile granulosa cell tumors of the ovary. Arch Pathol Lab Med 1989;113/1:40-46.
17. Calaminus G, Wessalowski R, Harms D, Gobel U: Juvenile granulosa cell tumors of the ovary in children and adolescents: Results from 33 patients registered in a prospective cooperative study. Gynecol Oncol 1997;65:447-452.
18. Young RH, Dickersin GR, Scully RE: Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cass. Am J Surg Pathol 1984;8:575-596.
19. Vassal G, Flamant F, Caillaud J, Demeocq F, Nihoul-Fekete C, Lemerle J: Juvenile granulosa cell tumor of the ovary in children: A clinical study of 15 cases. J Clin Oncol 1988;6:990-995.
20. Segal R, DePetrillo A, Thomas G: Clinical review of adult granulosa cell tumors of the ovary. Gynecol Oncol 1995;56:338-344.
21. Piura B, Nemet D, Yanai-Inbar I, Cohen Y, Glezerman M: Granulosa cell tumor of the ovary: A study of 18 cases. J Surg Oncol 1994;55/2: 71-77.
22. Williams S, Blessing J, Liao S, Ball H, Hanjani P: Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: A trial of the Gynecologic Oncology Group. J Clin Oncol 1994;12:701-706.
23. Hines JF, Khalifa MA, Moore JL, Fine KP, Lage JM, Barnes WA: Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: A case report and review of the literature. Gynecol Oncol 1996;60:484-488.
24. Malkasian GD, Webb MJ, Jorgensen EO: Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas. Obstet Gynecol 1974;44:885-888.
25. Jacobs AJ, Deppe G, Cohen CJ: Combination chemotherapy of ovarian granulosa cell tumor with cis-platinum and doxorubicin. Gynecol Oncol 1982;14:294-297.
26. Colombo N, Sessa C, Landoni F: Cisplatin, vinblastine and bleomycin combination chemotherapy in metastatic granulosa cell tumour of the ovary. Obstet Gynecol 1986;67:265.
27. Kaye SB, Davies E: Cyclophosphamide, adriamycin, and cis-platinum for the treatment of advanced granulosa cell tumor, using serum estradiol as a tumor marker. Gynecol Oncol 1986;24/2:261-264.
28. Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer CA, Saul PB, Wharton JT: Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 1987;70:765-769.
29. Zambetti M, Escobedo A, Pilotti S, De Palo G: Cisplatinum/vinblastine/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol 1990;36:317-320.
30. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT: Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol 1996;87:527-531.
31. Schwartz PE, MacLusky N, Sakamoto H, Eisenfeld A: Steroid-receptor proteins in nonepithelial malignancies of the ovary. Gynecol Oncol 1983;15:305-315.
32. Malik ST, Slevin ML: Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary - A new therapeutic approach? Br J Cancer 1991;63:410-411.
33. Kauppila A, Bangah M, Burger H, Martikainen H: GnRH agonist analog therapy in advanced/ recurrent granulosa cell. Gynecol Endocrinol 1992;6:271-274.
34. Fishman A, Kudelka AP, Tresukosol D, Edwards CL, Freedman RS, Kaplan AL, Girtanner RE, Kavanagh JJ: Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med 1996;41:393-396.
35. Roth LM, Anderson MC, Govan AD, Langley FA, Gowing NF, Woodcock AS: Sertoli-Leydig cell tumors: A clinicopathologic study of 34 cases. Cancer 1981;48:187-197.
36. Zaloudek C, Norris HJ: Sertoli-Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms. Am J Surg Pathol 1984;8:405-418.
37. Young RH, Scully RE: Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol 1985;9:543-569.
38. Young RH, Welch WR, Dickersin GR, Scully RE: Ovarian sex cord tumor with annular tubules: Review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 1982;50: 1384-1402.
39. McCluggage WG, Sloan JM, Murnaghan M, White R: Gynandroblastoma of ovary with juvenile granulosa cell component and heterologous intestinal type glands. Histopathology 1996;29:253-257.
40. Taylor HB, Norris HJ: Lipid cell tumors of the ovary. Cancer 1967;20:1953-1962.
41. Garde JR, Jones MA, McAfee R, Tarraza HM: Extragenital malignant mixed mullerian tumor: Review of the literature. Gynecol Oncol 1991;43:186-190.
42. Noorduyn LA, Herman CJ: The relation between mixed mesodermal tumors and adenocarcinomas of the ovary. An immunopathologic study. Eur J Cancer Clin Oncol 1987;23: 157-162.
43. Norris HJ, Roth E, Tylor HB: Mesenchymal tumors of the uterus. II. A clinical and pathologic study of 31 mixed mesodermal tumors. Obstet Gynecol 1966;28:57-63.
44. Hernandez W, DiSaia PJ, Morrow CP, Townsend DE: Mixed mesodermal sarcoma of the ovary. Obstet Gynecol 1977;49:59-63.
45. Hanjani P, Petersen RO, Lipton SE, Nolte SA: Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: Report of eight cases and review of literature. Obstet Gynecol Surv 1983;38:537-545.
46. Morrow CP, d'Ablaing G, Brady LW, Blessing JA, Hreshchyshyn MM: A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: A Gynecologic Oncology Group study. Gynecol Oncol 1984;18:278-292.
47. Dinh TV, Slavin RE, Bhagavan BS, Hannigan EV, Tiamson EM, Yandell RB: Mixed mesodermal tumors of the ovary: A clinicopathologic study of 14 cases. Obstet Gynecol 1988; 72:409-412.
48. Terada KY, Johnson TL, Hopkins M, Roberts JA: Clinicopathologic features of ovarian mixed mesodermal tumors and carcinosarcomas. Gynecol Oncol 1989;32:228-232.
49. Dictor M: Malignant mixed mesodermal tumor of the ovary: A report of 22 cases. Obstet Gynecol 1985;65:720-724.
50. George M, Pejovic MH, Kramar A: Uterine sarcomas: Prognostic factors and treatment modalities - Study on 209 patients. Gynecol Oncol 1986;24:58-67.
51. Lele SB, Piver MS, Barlow JJ: Chemotherapy in management of mixed mesodermal tumors of the ovary. Gynecol Oncol 1980;10:298-302.
52. Morrow CP, Bundy BN, Hoffman J, Sutton G, Homesley H: Adriamycin chemotherpay for malignant mixed mesodermal tumor of the ovary. A Gynecologic Oncology Group Study. Am J Clin Oncol 1986;9:24-26.
53. Wheelock J, Hancock K, Smith K: Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary. Cancer Treat Rep 1987;71:1275-1276.
54. Suggs CL, Lee JL Jr, Choi H, Lewis GC: Malignant mixed mesodermal tumors of the ovary. A report of 13 cases. Am J Clin Oncol 1988;11: 12-15.
55. Andersen WA, Young DE, Peters WA, Smith EB, Bagley CM, Taylor PT: Platinum-based combination chemotherapy for malignant mixed mesodermal tumors of the ovary. Gynecol Oncol 1989;32:319-322.
56. Plaxe SC, Dottino PR, Goodman HM, Deligdisch L, Idelson M, Cohen CJ: Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin- and cis-platinum-based chemotherapy. Gynecol Oncol 1990;37:244-249.
57. Plaxe SC, Dottino PR, Lipsztein R, Dalton J, Cohen CJ: Clinical features and treatment outcome of patients with epithelial carcinoma of the ovary metastatic to the central nervous system. Obstet Gynecol 1990;75:278-281.
58. Baker TR, Piver MS, Caglar H, Piedmonte M: Prospective trial of cisplatin, adriamycin, and dacarbazine in metastatic mixed mesodermal sarcomas of the uterus and ovary. Am J Clin Oncol 1991;14:246-250.
59. Simon SR, Wang SE, Uhl M, Shackney S: Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazine. Gynecol Oncol 1991;41:161-166.
60. Cunningham MJ, Brooks JS, Noumoff JS: Treatment of primary ovarian angiosarcoma with ifosfamide and doxorubicin. Gynecol Oncol 1994;53:265-268.
61. Sutton GP, Blessing JA, Homesley HD, Malfetano JH: A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: A Gynecologic Oncology Group study. Gynecol Oncol 1994;53:24-26.
62. DiSilvestro PA, Gajewski WH, Ludwig ME, Kourea H, Sung J, Granai CO: Malignant mixed mesodermal tumors of the ovary. Obstet Gynecol 1995;86:780-782.
63. Patsner B, Greenberg S: Mesna, doxorubicin, ifosfamide, and dacarbazine chemotherapy for ovarian mixed mullerian sarcoma: Report of four cases. Gynecol Oncol 1995;58:386-388.
64. Patel T, Ohri SK, Sundaresan M, Jackson J, Desa LA, Davey AT, Spencer J: Metastatic angiosarcoma of the ovary. Eur J Surg Oncol 1991;17:295-299.
65. Norris HJ, Jensen RD: Relative frequency of ovarian neoplasms in children and adolescents. Cancer 1972;30:713-719.
66. Stamp GW, McConnell EM: Malignancy arising in cystic ovarian teratomas. A report of 24 cases. Br J Obstet Gynaecol 1983;90:671-675.
67. Sell A, Sogaard H, Norgaard-Pedersen B: Serum alpha-fetoprotein as a marker for the effect of post-operative radiation therapy and/or chemotherapy in eight cases of ovarian endodermal sinus tumour. Int J Cancer 1976;18: 574-580.
68. Newlands ES, Holden L, Bagshawe KD: Tumour markers and POMB/ACE chemotherapy in the management of ovarian germ cell tumours (GCTs). Int J Biol Markers 1988;3/3: 185-192.
69. Altaras MM, Goldberg GL, Levin W, Bloch B, Darge L, Smith JA: The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas. Gynecol Oncol 1988;30/ 1:26-34.
70. Billmire DF, Grosfeld JL: Teratomas in childhood: Analysis of 142 cases. J Pediatr Surg 1986;21:548-551.
71. Hawkins EP, Finegold MJ, Hawkins HK, Krischer JP, Starling KA, Weinberg A: Nongerminomatous malignant germ cell tumors in children. A review of 89 cases from the Pediatric Oncology Group, 1971-1984. Cancer 1986; 58:2579-2584.
72. Mueller C, Topkins P, Lapp WA: Dysgerminoma of the ovary: An analysis of 427 cases. Am J Obstet Gynecol 1950;60:153-159.
73. Asadourian LA, Taylor HB: Dysgerminoma. An analysis of 105 cases. Obstet Gynecol 1969; 33:370-379.
74. Teter J, Boczkowski K: Occurrence of tumors in dysgenetic gonads. Cancer 1967;20:1301-1310.
75. Schellhas HF, Trujillo JM, Rutledge FN, Cork A: Germ cell tumors associated with XY gonadal dysgenesis. Am J Obstet Gynecol 1971; 109:1197-1204.
76. Schwartz IS, Cohen CJ, Deligdisch L: Dysgerminoma of the ovary associated with true hermaphroditism. Obstet Gynecol 1980;56:102-106.
77. Talerman A, Jarabak J, Amarose AP: Gonadoblastoma and dysgerminoma in a true hermaphrodite with a 46,XX karyotype. Am J Obstet Gynecol 1981;140:475-477.
78. Rodriguez E, Melamed J, Reuter V, Chaganti RS: Chromosome 12 abnormalities in malignant ovarian germ cell tumors. Cancer Genet Cytogenet 1995;82/1:62-66.
79. Schulman LP, Muram D, Marina N, Jones C, Portera JC, Wachtel SS, Simpson JL, Elias S: Lack of heritability in ovarian germ cell malignancies. Am J Obstet Gynecol 1994;170:1803-1808.
80. Young RH: New and unusual aspects of ovarian germ cell tumors. Am J Surg Pathol 1993; 17:1210-1224.
81. Farahmand S, Marchetti D, Asirwatham J, Dewey M: Ovarian endodermal sinus tumour associated with pregnancy: Review of the literature. Gynecol Oncol 1991;41:156-160.
82. Walker AH, Ross RK, Pike MC, Henderson BE: A possible rising incidence of malignant germ cell tumours in young women. Br J Cancer 1984;49:669-672.
83. Huntington RW, Bullock WK: Yolk sac tumors of the ovary. Cancer 1970;25:1357-1367.
84. Norris HJ, Zirkin HJ, Benson WL: Immature (malignant) teratoma of the ovary: A clinical and pathologic study of 58 cases. Cancer 1976; 37:2359-2372.
85. Krepart G, Smith JP, Rutledge F, Delclos L: The treatment for dysgerminoma of the ovary. Cancer 1978;41:986-990.
86. Peckham M, Barrett A, Liew KH, Horwich A, Robinson B, Dobbs HJ, McElwain TJ, Hendry WF: The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer 1983;47:613-619.
87. Williams S, Birch R, Einhorn L, Irwin L, Greco F, Loehrer P: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 1987;316:1435-1440.
88. Micha JP, Kucera PR, Berman ML, Romansky S, Flamm M, Reynolds J, DiSaia PJ: Malignant ovarian germ cell tumors: A review of thirty-six cases. Am J Obstet Gynecol 1985;152:842-846.
89. Sawada M, Okudaira Y, Matsui Y, Nishiura H, Iwasaki T, Kasamatsu H: Cisplatin, vinblastine, and bleomycin therapy of yolk sac (endodermal sinus) tumor of the ovary. Gynecol Oncol 1985;20/2:162-169.
90. Segelov E, Campbell J, Ng M, Tattersall M, Rome R, Free K, Hacker N, Friedlander ML: Cisplatin-based chemotherapy for ovarian germ cell malignancies: The Australian experience. J Clin Oncol 1994;12:378-384.
91. Bower M, Fife K, Holden L, Paradinas FJ, Rustin GJ, Newlands ES: Chemotherapy for ovarian germ cell tumours. Eur J Cancer 1996; 32A:593-597.
92. Peccatori F, Bonazzi C, Chiari S, Landoni F, Colombo N, Mangioni C: Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients. Obstet Gynecol 1995;86:367-372.
93. Christmas TJ, Doherty AP, Rustin GJ, Seckl MJ, Newlands ES: Primary retroperitoneal germ cell tumours: Excision via a thoracoabdominal extraperitoneal approach. Br J Surg 1997;84:1022-1025.
94. Munkarah A, Gershenson DM, Levenback C, Silva EG, Messing MJ, Morris M, Burke TW: Salvage surgery for chemorefractory ovarian germ cell tumors. Gynecol Oncol 1994;55/2: 217-223.
95. Williams S, Blessing J, DiSaia P, Major F, Ball H, Liao S: Second-look laparotomy in ovarian germ cell tumors: The Gynecologic Oncology Group experience. Gynecol Oncol 1994;52/3:287-291.
96. Culine S, Lhomme C, Michel G, Leclere J, Duvillard P, Droz JP: Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy. J Surg Oncol 1996;62/1:40-45.
97. Malkasian G, Symmonds R: Treatment of the unilateral encapsulated ovarian dysgerminoma. Am J Obstet Gynecol 1964;90:379-382.
98. Dark G, Bower M, Newlands E, Paradinas F, Rustin G: Surveillance policy for stage I ovarian germ cell tumours. J Clin Oncol 1997;15: 620-624.
99. Cullen MH, Stenning SP, Parkinson MC, Fossa SD, Kaye SB, Horwich AH, Harland SJ, Williams MV, Jakes R: Short-course adjuvant chemotherapy in high-risk stage I non-seminomatous germ cell tumors of the testis: A Medical Research Council report. J Clin Oncol 1996;14:1106-1113.
100. Mitchell MF, Gershenson DM, Soeters RP, Eifel PJ, Delclos L, Wharton JT: The long-term effects of radiation therapy on patients with ovarian dysgerminoma. Cancer 1991;67: 1084-1090.
101. Mencel PJ, Motzer RJ, Mazumdar M, Vlamis V, Bajorin DF, Bosl GJ: Advanced seminoma: Treatment results, survival, and prognostic factors in 142 patients. J Clin Oncol 1994; 12/1:120-126.
102. Einhorn LH, Donohue J: Cis-Diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977;87/3: 293-298.
103. Bower M, Newlands ES, Holden L, Rustin GJ, Begent RH: Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy. Ann Oncol 1997;8:477-483.
104. Bower M, Brock C, Holden L, Nelstrop A, Makey AR, Rustin GJ, Newlands ES: POMB/ ACE chemotherapy for mediastinal germ cell tumours. Eur J Cancer 1997;33:838-842.
105. Smith JP, Rutledge F: Advances in chemotherapy for gynecologic cancer. Cancer 1975; 36:669-674.
106. Gershenson DM, Copeland LJ, Kavanagh JJ, Cangir A, Del Junco G, Saul PB, Stringer CA, Freedman RS, Edwards CL, Wharton JT: Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vincristine, dactinomycin, and cyclophosphamide. Cancer 1985;56:2756-2761.
107. Greene MH, Boice JD, Greer BE, Blessing JA, Dembo AJ: Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: A study of five randomized clinical trials. N Engl J Med 1982;307:1416-1421.
108. Williams S, Blessing J, Hatch K, Homesley H: Chemotherapy of advanced dysgerminoma: Trials of the Gynecologic Oncology Group. J Clin Oncol 1991;9:1950-1955.
109. Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, Silva EG, Wharton JT: Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol 1990;8: 715-720.
110. Gershenson DM: Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 1988;6/2:270-275.
111. Rustin GJ, Newlands ES, Begent RH, Bagshawe KD: Fertility after chemotherapy for ovarian germ cell tumours. J Clin Oncol 1988;6:1520-1521.
112. Wu PC, Huang RL, Lang JH, Huang HF, Lian LJ, Tang MY: Treatment of malignant ovarian germ cell tumors with preservation of fertility: A report of 28 cases. Gynecol Oncol 1991;40/1:2-6.
113. Gonzalez-Lira G, Escudero-De Los Rios P, Salazar-Martinez E, Lazcano-Ponce EC: Conservative surgery for ovarian cancer and effect on fertility. Int J Gynaecol Obstet 1997; 56/2:155-162.
114. Norris HJ, Taylor HB: Prognosis of granulosa-theca tumors of the ovary. Cancer 1968;21: 255-263.
115. Ayhan A, Tuncer ZS, Tuncer R, Mercan R, Yuce K, Ayhan A: Granulosa cell tumor of the ovary. A clinicopathological evaluation of 60 cases. Eur J Gynaecol Oncol 1994;15:320-324.
116. Pankratz E, Boyes DA, White GW, Galliford BW, Fairey RN, Benedet JL: Granulosa cell tumors. A clinical review of 61 cases. Obstet Gynecol 1978;52:718-723.
117. Stenwig JT, Hazekamp JT, Beecham JB: Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 1979;7:136-152.
118. Gordon A, Lipton D, Woodruff JD: Dysgerminoma: A review of 158 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynecol 1981;58:497-504.
119. de Palo G, Pilotti S, Kenda R, Ratti E, Musumeci R, Mangioni C, di Re F, Lattuada A, Conti U, Cefis F, Recanatini L, Carinelli S, Rossi G: Natural history of dysgerminoma. Am J Obstet Gynecol 1982;143:799-807.
120. Talerman A, Huyzinga WT, Kuipers T: Dysgerminoma. Clinicopathologic study of 22 cases. Obstet Gynecol 1973;41/1:137-147.
121. Kurman RJ, Norris HJ: Endodermal sinus tumor of the ovary: A clinical and pathologic analysis of 71 cases. Cancer 1976;38:2404-2419.
122. Nogales F, Favara B, Major F, Silverberg S: Immature teratoma of the ovary with a neural component ('solid teratoma'). Hum Pathol 1976;7:625-642.
123. Nielsen S, Gaffey TA, Malkasian GD: Immature ovarian teratoma: A review of 14 cases. Mayo Clin Proc 1986;6:110-115.
124. Ayhan A, Tuncer ZS, Yanik F, Bukulmez O, Yanik A, Kucukali T: Malignant germ cell tumors of the ovary: Hacettepe Hospital experience. Acta Obstet Gynecol Scand 1995; 74:384-390.
125. Cangir A, Smith J, van Eys J: Improved prognosis in children with ovarian cancers following modified VAC (vincristine sulfate, dactinomycin, and cyclophosphamide) chemotherapy. Cancer 1978;42:1234-1238.
126. Carlson RW, Sikic BI, Turbow MM, Ballon SC: Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary. J Clin Oncol 1983;1:645-651.
127. Culine S, Lhomme C, Kattan J, Michel G, Duvillard P, Droz JP: Cisplatin-based chemotherapy in the management of germ cell tumors of the ovary: The Institut Gustave Roussy Experience. Gynecol Oncol 1997;64/ 1:160-165.
128. Gershenson DM, Kavanagh JJ, Copeland LJ, Del Junco G, Cangir A, Saul PB, Stringer CA, Edwards CL, Wharton JT: Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin. Cancer 1986;57:1731-1737.
129. Smales E, Peckham JM: Chemotherapy of germ-cell ovarian tumours: First-line treatment with etoposide, bleomycin and cisplatin or carboplatin. Eur J Cancer Clin Oncol 1987; 23:469-474.
130. Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA: Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report). Cancer 1985;56/2:243-248.
131. Williams S, Blessing J, Moore D, Homesley H, Adcock L: Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med 1989;111/ 1:22-27.